Vivos Therapeutics Inc
VVOS
Market Cap$26.09M
Close$
Share Statistics
| Market cap | $26.09 Million |
|---|---|
| Enterprise Value | $26.35 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.68 |
| Beta | 6.99 |
| Outstanding Shares | 8,595,288 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.39 |
|---|---|
| PEG | -126.25 |
| Price to Sales | 5.12 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.8 |
| Enterprise Value to EBIT | -2.43 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.59 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Vivos Therapeutics Inc
115 employeesVivos Therapeutics Inc. is a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep disordered breathing, including obstructive sleep apnea (OSA). Vivos believes that...